TrialTherapeutic advances in cardiovascular disease2018

Results of 5-year follow-up study in patients with peripheral artery disease treated with PL-VEGF165 for intermittent claudication.

Roman Deev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.